Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 11293927 was granted and assigned to Ribon Therapeutics on April, 2022 by the United States Patent and Trademark Office. | 11293927 | April 5, 2022 | |||||||
Patent 11008308 was granted and assigned to Ribon Therapeutics on May, 2021 by the United States Patent and Trademark Office. | 11008308 | May 18, 2021 | |||||||
11566020 | January 31, 2023 | ||||||||
11535621 | December 27, 2022 | ||||||||
Patent 10562891 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office. | 10562891 | February 18, 2020 | |||||||
Patent 11014913 was granted and assigned to Ribon Therapeutics on May, 2021 by the United States Patent and Trademark Office. | 11014913 | May 25, 2021 | |||||||
Patent 10550105 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office. | 10550105 | February 4, 2020 | |||||||
10870641 | December 22, 2020 | ||||||||
Patent 11958837 was granted and assigned to Ribon Therapeutics on April, 2024 by the United States Patent and Trademark Office. | 11958837 | April 16, 2024 | |||||||
11691969 | July 4, 2023 |